Oritavancin as sequential therapy for Gram-positive bloodstream infections.

Texidor WM, Miller MA, Molina KC, Krsak M, Calvert B, Hart C, Storer M, Fish DN

DOI: 10.1186/s12879-023-08725-8
Published: 2024 Jan 24
Container: BMC infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12879-023-08725-8,
  title = {Oritavancin as sequential therapy for Gram-positive bloodstream infections.},
  author = {Texidor WM and Miller MA and Molina KC and Krsak M and Calvert B and Hart C and Storer M and Fish DN},
  year = {2024},
  journal = {BMC infectious diseases},
  doi = {10.1186/s12879-023-08725-8},
  url = {https://doi.org/10.1186/s12879-023-08725-8}
}

RIS

TY  - JOUR
TI  - Oritavancin as sequential therapy for Gram-positive bloodstream infections.
AU  - Texidor WM
AU  - Miller MA
AU  - Molina KC
AU  - Krsak M
AU  - Calvert B
AU  - Hart C
AU  - Storer M
AU  - Fish DN
PY  - 2024
JO  - BMC infectious diseases
DO  - 10.1186/s12879-023-08725-8
UR  - https://doi.org/10.1186/s12879-023-08725-8
ER  -

APA

WM, T., MA, M., KC, M., M, K., B, C., C, H., M, S., & DN, F. (2024). Oritavancin as sequential therapy for Gram-positive bloodstream infections.. BMC infectious diseases. https://doi.org/10.1186/s12879-023-08725-8

Source records

pubmed · retrieved 2026-09-27T13:21:54.646Z